http://orcid.org/0000-0003-3892-8376
References
- Verghese P, Miyashita Y. Neonatal polycystic kidney disease. Clin Perinatol. 2014;41(3):543–560.
- Sweeney WE Jr, Avner ED. Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol. 2011;26(5):675–692.
- Greene LF, Feinzaig W, Dahlin DC. Multicystic dysplasia of the kidney: with special reference to the contralateral kidney. J Urol. 1971;105(4):482–487.
- Adeva M, El-Youssef M, Rossetti S, et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore). 2006;85(1):1–21.
- Zerres K, Mücher G, Becker J, et al. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet. 1998;76(2):137–144.
- Telega G, Cronin D, Avner ED. New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications. Pediatr Transplant. 2013;17(4):328–335.
- Erger F, Brüchle NO, Gembruch U, et al. Prenatal ultrasound, genotype, and outcome in a large cohort of prenatally affected patients with autosomal-recessive polycystic kidney disease and other hereditary cystic kidney diseases. Arch Gynecol Obstet. 2017;295(4):897–906.
- Fick GM, Johnson AM, Strain JD, et al. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;3(12):1863–1870.
- Mallik M, Watson AR. Antenatally detected urinary tract abnormalities: more detection but less action. Pediatr Nephrol. 2008;23(6):897–904.
- Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med. 2003;141(2):91–101.
- Avni FE, Garel C, Cassart M, et al. Imaging and classification of congenital cystic renal diseases. Am J Roentgenol. 2012;198(5):1004–1013.
- Hains DS, Bates CM, Ingraham S, et al. Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol. 2009;24(2):233–241.
- Bajwa ZH, Gupta S, Warfield CA, et al. Pain management in polycystic kidney disease. Kidney Int. 2001;60(5):1631–1644.
- Robson WL, Leung AK, Thomason MA. Multicystic dysplasia of the kidney. Clin Pediatr. 1995;34(1):32–40.
- Verghese P, Kim Y. Unilateral localized cystic kidney. Pediatr Nephrol. 2011;26(5):713–716.
- Patil S. Intraoral desmoplastic fibroblastoma: a rare presentation. J Sci Soc. 2015;42:106–108.
- Kocyigit I, Yilmaz MI, Unal A, et al. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease. Am J Nephrol. 2013;38(3):218–225.
- Meijer E, Drenth JP, d’Agnolo H, et al. Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am J Kidney Dis Off J Natl Kidney Found. 2014;63(3):446–455.
- Higashihara E, Torres VE, Chapman AB, et al. Tolvaptan in autosomal dominant polycystic kidney disease: three years’ experience. Clin J Am Soc Nephrol. 2011;6(10):2499–2507.